Stocks and Investing Stocks and Investing
Wed, March 11, 2020
Tue, March 10, 2020
Mon, March 9, 2020
Sun, March 8, 2020
Fri, March 6, 2020

Matt Miksic Maintained (ABT) at Buy with Decreased Target to $94 on, Mar 6th, 2020


Published on 2024-10-26 23:20:49 - WOPRAI, Matt Miksic
  Print publication without navigation


Matt Miksic of Credit Suisse, Maintained "Abbott Laboratories" (ABT) at Buy with Decreased Target from $104 to $94 on, Mar 6th, 2020.

Matt has made no other calls on ABT in the last 4 months.



There are 10 other peers that have a rating on ABT. Out of the 10 peers that are also analyzing ABT, 4 agree with Matt's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Amit Hazan of "Goldman Sachs" Initiated at Hold and Held Target at $96 on, Thursday, February 13th, 2020
  • Marie Thibault of "BTIG" Initiated at Hold on, Thursday, February 6th, 2020
  • Danielle Antalffy of "SVB Leerink" Maintained at Hold with Increased Target to $102 on, Thursday, January 23rd, 2020
  • Christopher Pasquale of "Guggenheim" Downgraded from Strong Buy to Hold on, Thursday, January 2nd, 2020


These are the ratings of the 6 analyists that currently disagree with Matt


  • Joanna Wiensch of "Citigroup" Initiated at Strong Buy and Held Target at $96 on, Thursday, March 5th, 2020
  • Matthew Taylor of "UBS" Maintained at Strong Buy with Increased Target to $105 on, Thursday, January 23rd, 2020
  • Rick Wise of "Stifel" Maintained at Strong Buy with Increased Target to $104 on, Thursday, January 23rd, 2020
  • Larry Biegelsen of "Wells Fargo" Maintained at Buy with Increased Target to $103 on, Thursday, January 23rd, 2020
  • Jayson Bedford of "Raymond James" Maintained at Buy with Increased Target to $99 on, Thursday, January 23rd, 2020
  • David Lewis of "Morgan Stanley" Maintained at Buy with Increased Target to $101 on, Tuesday, December 17th, 2019